Hypertension drug PMS-Losartan-HCTZ recalled due to labelling error

Pharmascience Inc., in consultation with Health Canada, is recalling one lot of PMS-Losartan-HCTZ due to a labelling error on the blister pack (see photo below). The printed boxes of the product show the proper dosage “Losartan-HCTZ100/25mg,” while some blisters or inner packages incorrectly say “Losartan-HCTZ 100/12.5mg.” The product is packaged with 100/25mg tablets. Taking more of the drug than prescribed could have serious health effects.

Labelling

If you are taking this product, check the packaging for the lot number. If this is the affected lot, return the product to your pharmacist and obtain a replacement. Report any adverse events using these products to Health Canada .